SEPTInvestingStart Free

ALKS 8-K: Legal settlement

Alkermes

Filed with the SEC on · accession 0001193125-26-456888

ALKS filed a 8-K (current report) with the SEC on Nov 12, 2026. Alkermes entered into a confidential settlement and license agreement with Teva resolving a patent infringement lawsuit over Teva's ANDA for a generic version of Alkermes' LYBALVI.

Summary of the filing

Alkermes entered into a confidential settlement and license agreement with Teva resolving a patent infringement lawsuit over Teva's ANDA for a generic version of Alkermes' LYBALVI. Under the agreement, Teva receives a limited license to launch its generic product in the U.S. beginning November 12, 2039 (or May 12, 2040 with pediatric exclusivity), and the parties filed a stipulation to dismiss the litigation with prejudice.

For details, click here →How to read a 8-K →

Key details

Registrant; parent of alkermes, inc. and alkermes pharma ireland limitedAlkermes plc
Wholly-owned indirect subsidiary; party to the settlement agreementAlkermes, Inc.
Wholly-owned indirect subsidiary; party to the settlement agreementAlkermes Pharma Ireland Limited
Counterparty; anda filer receiving a limited license to market generic lybalviTeva Pharmaceuticals, Inc.
Secretary, alkermes plcDavid J. Gaffin

✦ Ask GOAX AI about this filing — what it means for ALKS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ALKS?

Click here

Frequently asked questions

What did ALKS file with the SEC on Nov 12, 2026?

ALKS filed a 8-K (Legal settlement). Alkermes entered into a confidential settlement and license agreement with Teva resolving a patent infringement lawsuit over Teva's ANDA for a generic version of Alkermes' LYBALVI. Under the agreement, Teva receives a limited license to launch its generic product in the U.S. beginning November 12, 2039 (or May 12, 2040 with pediatric exclusivity), and the parties filed a stipulation to dismiss the litigation with prejudice.

What does a legal settlement mean for ALKS stock?

A settlement removes uncertainty; the stock often reacts to whether the amount is bigger or smaller than investors expected.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other ALKS SEC filings

Get alerts when ALKS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
ALKS overviewALKS analysisALKS newsLatest SEC filings